A5073516436- Cancer Immunotherapy and Biomarkers
- Non-Invasive Vital Sign Monitoring
- CAR-T cell therapy research
- Lung Cancer Research Studies
- Corneal Surgery and Treatments
- Economic and Financial Impacts of Cancer
- Indoor and Outdoor Localization Technologies
- Lymphoma Diagnosis and Treatment
- Control Systems in Engineering
- Photodynamic Therapy Research Studies
- Sensorless Control of Electric Motors
- Chronic Lymphocytic Leukemia Research
- Advanced Breast Cancer Therapies
- Renal cell carcinoma treatment
- Advanced Wireless Communication Technologies
- ECG Monitoring and Analysis
- Effects and risks of endocrine disrupting chemicals
- Nanoplatforms for cancer theranostics
- Heart Rate Variability and Autonomic Control
- Lung Cancer Treatments and Mutations
- Elevator Systems and Control
- Microplastics and Plastic Pollution
- Esophageal Cancer Research and Treatment
- Health Systems, Economic Evaluations, Quality of Life
- Ovarian cancer diagnosis and treatment
Southeast University
2024-2025
State Key Laboratory of Metastable Materials Science and Technology
2024
Renji Hospital
2024
Shanghai Jiao Tong University
2024
Yanshan University
2024
BeiGene (China)
2018-2022
Yangtze University
2010
Abstract Human vital-sign sensing using electromagnetic wave has emerged as a promising technology for the noninvasive monitoring of individuals’ health status. Here, modular reprogrammable metasurface system is presented to suppress noise in human respiration sensing. The proposed Biological Metasurface ( BioMeta ) provides three-dimensional dynamic control over wavefront shaping and thus can reduce interference from limb motions. This capability allows acquire data accurately reliably...
Passive wireless human sensing has attracted increasing attention due to its non-contact nature and robustness under different lighting conditions. This paper proposes a system for multiperson detection vital-sign (i.e., respiration heartbeat) monitoring using space-time-coding (STC) reconfigurable intelligent surfaces (RISs). Specifically, the proposed scans area of interest (AoI) by STC RIS-generated harmonic beams. Simultaneously, specific beams are assigned detected persons sensing....
Retracted.
Background: Effective treatment choices for patients (pts) with relapsed/refractory (R/R) mature T- and NK-cell neoplasms after failure of standard therapies are limited. Tislelizumab (TIS), a humanized anti–PD-1 mAb, demonstrated outstanding efficacy favorable safety in pts R/R classical Hodgkin lymphoma or solid tumors. Aims: To evaluate the TIS neoplasms. Methods: This was global, multicenter, single-arm, open-label, phase 2 study (NCT03493451). Pts were enrolled into 3 cohorts stratified...